Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Dow
AstraZeneca
Moodys
Boehringer Ingelheim
McKesson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Imiglucerase - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for imiglucerase and what is the scope of patent protection?

Imiglucerase is the generic ingredient in one branded drug marketed by Genzyme and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Recent Clinical Trials for imiglucerase

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
SanofiPhase 3
Genzyme, a Sanofi CompanyPhase 2
University Hospital, Clermont-FerrandPhase 2

See all imiglucerase clinical trials

Pharmacology for imiglucerase

US Patents and Regulatory Information for imiglucerase

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-002 Sep 22, 1999 RX Yes Yes   Start Trial   Start Trial   Start Trial
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-001 May 23, 1994 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for imiglucerase

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-001 May 23, 1994   Start Trial   Start Trial
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-002 Sep 22, 1999   Start Trial   Start Trial
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-002 Sep 22, 1999   Start Trial   Start Trial
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-001 May 23, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Colorcon
Dow
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.